Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.50
Bid: 1,604.00
Ask: 1,604.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.031%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,599.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: UK Government Raises GBP4.2 Billion From Lloyds Sale

Wed, 26th Mar 2014 11:17

LONDON (Alliance News) - The following is a summary of top news stories Wednesday.
----------
COMPANIES
----------
The UK government said it has raised GBP4.2 billion in its sale of a second tranche of Lloyds Banking Group PLC shares, meaning it has now recouped GBP7.41 billion of the roughly GBP21 million it had to pump into the bank during the financial crisis. In a statement, UK Financial Investments Ltd, which manages the government's stakes in bailed out banks, said it had sold a 7.8% stake in Lloyds at 75.5 pence a share, taking the UK government stake down to 24.9%, from 32.7%. UKFI sold an initial 6% stake in the bank last September at 75 pence a share, raising about GBP3.21 billion for government coffers.
----------
Legal & General Group PLC has forecast that Chancellor of the Exchequer George Osborne's changes to pensions rules could result in the GBP12 billion a year annuity market more than halving in size, according to the Financial Times. The measures introduced in the Chancellor's 2014 Budget will give savers savers more flexibility in how they use their pension pots in retirement. According to the FT, Legal & General said the measures could cut total annuity sales by all providers to GBP4.4 billion.
----------
Legal & General also said it has won a bulk annuity contract with ICI Pension Fund, covering GBP3.00 billion of its liabilities, as the life insurer moved to reinforce its expectation that it will exceed the GBP2.1 billion of annuity net flows in 2013. Legal & General said the deal is the largest ever bulk annuity contract arranged by a pension scheme in the UK.
----------
GlaxoSmithKline PLC said it had withdrawn its marketing authorisation application for the combined use of Meikinist and Tafinlar for the treatment of unresectable or metastatic melanoma with a BRAF V600 mutation in Europe. This was as a result of the Committee for Medicinal Products for Human Use within the European Medicines Agency indicating that the data provided by Glaxo had not allowed it to conclude on a benefit of the combined treatment. Glaxo said that it will re-submit its application for the combined treatment when it has further data from its ongoing Phase III programme.
----------
BG Group announced that it has secured a new exploration opportunity after being awarded new exploration acreage offshore Myanmar. The oil and gas major said it will operate a 45% equity on the A4 block and a 55% equity on the AD2 block, while it has also secured 45% equity non-operated acreage in blocks A7 and AD5, all of which are in the Rakhine Basin, offshore Myanmar. The company said that it has committed to a 3D seismic acquisition programme in each block along with its bidding partners, which it expects to begin in 2014/15 with options for future drilling.
----------
UK-based travel operator TUI Travel PLC said it remains on track to deliver first half results broadly in line with last year, excluding Easter, and is still confident of growing its underlying operating profit by 7% to 10% in the full financial year. In a trading update, Chief Executive Peter Long said the company was pleased with its performance during the winter trading season, with most of its programmes now almost fully sold, while trading of the summer season is so far in line with expectations.
----------
SSE PLC announced a major asset disposal plan, cost cutting initiatives and a freezing of UK household energy bills ahead of its full year results next week. The major UK energy supplier said that as part of its value programme, it is now planning asset and business disposals that will secure proceeds and debt reduction estimated to total around GBP1 billion. The company said it has started the disposal process which is expected to take two years, with the disposal of SSE's portfolio of PFI street lighting contracts already under way and a GBP500 million disposal of the company's onshore wind farms planned.
----------
Home emergency company Homeserve PLC said its expects its key profit measure to be in line with market expectations in its current financial year, as it also reiterated that costs related to the settling of previous regulatory issues in the UK had met its expectations. Last month it agreed to the final terms of a GBP30.6 million fine imposed by the Financial Conduct Authority following the regulator's probe into allegations that it mis-sold policies and mis-handled customer complaints. In its trading statement, the company re-iterated that all customers that may have been affected by what it called "historic practices" had now been contacted and the cost of the exercise was in line with its expectations. The company also said it expects its underlying pretax profit for the year to end-March to be in line with market expectations
----------
Phoenix Group Holdings PLC said it has agreed to sell Ignis Asset Management Ltd to Standard Life PLC in a GBP390 million cash deal, with the two life companies also agreeing to a long-term strategic asset management deal. The strategic deal will result in Standard Life managing assets for Phoenix's Life subsidiaries, including the potential to manage future books of assets that Phoenix may acquire. It also means that Phoenix is now solely focused on the management of closed life funds.
----------
EnQuest PLC said its pretax profit fell in its full year 2013 despite an increase in revenues, as costs and expenses hit the company. The oil and gas development and production company, with operations in the UK Continental Shelf said its pretax profit fell 18% to USD330.9 million from USD403.4 million in the previous year despite an 8.1% increase in revenues to USD961.2 million from USD889.5 million in 2012. The company said its revenues jumped as production increased 6.2% to 24,222 barrels of oil equivalent per day from 22,802 barrels per day the previous year, due to additional production from its Heather and Broom sites as well as its newly acquired Alba field offsetting marginally lower production from its Thistle site.
----------
MARKETS
----------
UK indices are pushing higher with life insurers leading the UK gains after shares in annuity provides plummeted last week on a market shake-up announced in the UK budget.
----------
FTSE 100: up 0.5% at 6637.54
FTSE 250: up 0.8% at 16277.26
AIM ALL-SHARE: up 0.2% at 852.98
----------
The euro is down against the dollar on mixed eurozone data reports.
----------
GBP-USD: up at USD1.6532
EUR-USD: down at USD1.3979

GOLD: up at USD1314.50 per ounce
OIL (Brent): up at USD107.07 a barrel

(changes since end of previous GMT day)
----------
ECONOMICS AND GENERAL
----------
British wage growth is starting to pick up and income and wages should rise so as to sustain economic growth, Bank of England policymaker Martin Weale told the Reading Post in an interview. "That's another favorable straw in the wind," he said. Economic growth last year appeared to be driven by consumer spending but investment now seems to be playing a bigger part, he observed. Weale said the economic picture will differ from one part of the country to other. "From the committee's point of view, it's the national picture which matters because we set monetary policy for the whole country, not just affluent parts," he said. Further, he urged companies to focus on export market for future growth. As the economy recovers, interest rates should return to more normal levels, central banker noted. But any increase in rates will be relatively gradual.
----------
German consumer confidence is expected to remain stable in April, a closely watched survey from the market research group GfK showed. The forward-looking consumer confidence index remain unchanged at 8.5%, in line with forecast. The economic outlook of consumers in March was back on the road toward recovery. The indicator gained 1.3 points to 33.2 points. Meanwhile, income expectations dropped three points to 45.6 points in March.
----------
Russia wants to boost its military presence on the Crimean Peninsula after annexing it from Ukraine, the Interfax news agency reported citing an unnamed defence official. The plan includes deploying Tupolev Tu-22M3 long-range bombers by 2016, as well as air-superiority and maritime patrol aircraft, and submarines. A helicopter carrier will be deployed in 2017."The need for these aircraft in the south was always there, but not is the right time that they return there," Interfax quoted the defence official said saying. Meanwhile, Ukrainian soldiers and their families have been leaving the peninsula, which became part of Russia after a majority supported accession in a referendum earlier this month. The soldiers have been leaving their weapons behind.
----------
The US aid package of USD1 billion in loan guarantees for Ukraine neared final passage as early as this week, after Democrats in the Senate on Tuesday dropped a provision sought by the International Monetary Fund. A fight over a provision to ratify long-waiting reforms at the IMF had stalled passage of the urgent aid measure for two weeks.
----------
Chinese Prime Minister Li Keqiang urged Malaysia to provide more information about missing flight MH370, amid relatives' anger at the authorities in Kuala Lumpur, news reports said. Li "urged Malaysia to provide detailed and accurate information" on the Malaysia Airlines flight, which data analysis indicated crashed into the southern Indian Ocean on March 8, the official Xinhua news agency reported. The Malaysian government and Malaysia Airlines have been widely criticized in China, in particular by relatives of the 154 Chinese passengers on board the Boeing 777-200.
----------
North Korea test-fired two missiles into the sea, an official in Seoul said, prompting condemnation from South Korea, Japan and the US. It was the latest of several such launches this week, as South Korean, Japanese and US leaders criticized the North's nuclear weapons programme during a meeting in the Netherlands. "North Korea fired a ballistic missile at 2:35 am (1735 GMT) and another at 2:45 am," the South Korean military was cited as saying by Yonhap News Agency. The missiles were fired from north of Pyongyang and flew about 650 kilometres before falling into the waters east of the Korean Peninsula, a spokesman for the South's Defence Ministry said.
----------
An Egyptian court adjourned the trial of Muslim Brotherhood chief Mohammed Badie and 682 alleged supporters to April 28, when it will announce its verdict in the death penalty case. The opening session Tuesday of the trial in the Minya Criminal Court heard prosecution witnesses, who accused the defendants of storming a police station and killing officers in August in the southern town of Udwa. Defence lawyers boycotted the hearing in protest at the death sentences presiding Judge Saeed Youssef handed down Monday to 529 people charged with similar offences.
----------
Copyright © 2014 Alliance News Limited. All Rights Reserved.


More News
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more
11 Oct 2023 07:47

LONDON BRIEFING: Stocks lower; GSK settles Zantac case in California

(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.

Read more
9 Oct 2023 08:16

TOP NEWS: GSK inks agreement with Zhifei to promote shingles vaccine

(Alliance News) - GSK PLC on Monday said it has reached an exclusive agreement with Chongqing Zhifei Biological Products Ltd to co-promote its shingles vaccine, Shingrix, in China.

Read more
9 Oct 2023 07:42

LONDON BRIEFING: Metro Bank secures deal to shore up finances

(Alliance News) - Stocks in London are set to open higher on Monday as interest rate expectations held steady despite Friday's bumper US nonfarm payrolls report.

Read more
9 Oct 2023 07:20

GSK inks deal to promote shingles vaccine in China

(Sharecast News) - GSK has entered into a new exclusive vaccine partnership in China that will extend the availability of its shingle vaccine Shingrix, which will see the UK-listed group generate £2.5bn over the next three years.

Read more
8 Oct 2023 11:36

Sunday newspaper round-up: Renewi, Metro Bank, New homes

(Sharecast News) - Some of Renewi's major shareholders are divided as to whether the recycling company should engage with Australian suitor Macquarie. One major shareholder has told Renewi's board that it should not until Macquarie raised its £636m bid, but another top ten shareholder told The Sunday Times that it should talk to the Australian outfit anyways. Macquarie has until 26 October to make a firm offer. - The Sunday Times

Read more
6 Oct 2023 08:17

GSK raises £885.6m from Haleon share sale

(Sharecast News) - GSK said on Friday that it has sold 270m shares in Haleon - the consumer health business it spun off last year - raising around £885.6m.

Read more
6 Oct 2023 07:57

UPDATE: GSK banks GBP886 million from Haleon share sale

(Alliance News) - GSK PLC on Friday said it received GBP885.6 million in gross proceeds from its sale of shares in consumer healthcare spin-off Haleon PLC.

Read more
6 Oct 2023 07:46

LONDON BRIEFING: Wetherspoon swings to profit; UK house prices fall

(Alliance News) - Stocks in London are called to open higher on Friday, as investors eye a key nonfarm payroll reading in the US.

Read more
5 Oct 2023 15:47

UK dividends calendar - next 7 days

Friday 6 October 
Admiral Group PLCdividend payment date
Alfa Financial Software Holdings PLCspecial dividend payment date
Anglo-Eastern Plantations PLCdividend payment date
Blackrock World Mining Trust PLCdividend payment date
Cairn Homes PLCdividend payment date
Dalata Hotel Group PLCdividend payment date
Drax Group PLCdividend payment date
Glanbia PLCdividend payment date
GlobalData PLCdividend payment date
Goodwin PLCdividend payment date
Greggs PLCdividend payment date
Intertek Group PLCdividend payment date
Irish Continental Group PLCdividend payment date
JPMorgan American Investment Trust PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Land Securities Group PLCdividend payment date
Personal Assets Trust PLCdividend payment date
Quartix Technologies PLCdividend payment date
Serco Group PLCdividend payment date
Walker Crips Group PLCdividend payment date
Warehouse REIT PLCdividend payment date
Zotefoams PLCdividend payment date
Monday 9 October 
Henderson Smaller Cos Investment Trust PLCdividend payment date
LondonMetric Property PLCdividend payment date
Tuesday 10 October 
LSL Property Services PLCdividend payment date
Wednesday 11 October 
Assura PLCdividend payment date
Rathbones Group PLCdividend payment date
Thursday 12 October 
Blackrock Latin American Investment Trust PLCex-dividend payment date
Breedon Group PLCex-dividend payment date
Diageo PLCdividend payment date
GSK PLCdividend payment date
Howden Joinery Group PLCex-dividend payment date
i3 Energy PLCex-dividend payment date
Invesco Bond Income Plus Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
JPMorgan Mid Cap Investment Trust PLCex-dividend payment date
Kingfisher PLCex-dividend payment date
MP Evans Group PLCex-dividend payment date
Macfarlane Group PLCdividend payment date
North American Income Trust PLCex-dividend payment date
Oxford Instruments PLCdividend payment date
Persimmon PLCex-dividend payment date
Personal Group Holdings PLCex-dividend payment date
Primary Health Properties PLCex-dividend payment date
Ruffer Investment Co Ltdex-dividend payment date
Senior PLCex-dividend payment date
Spirax-Sarco Engineering PLCex-dividend payment date
Strategic Equity Capital PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
Taylor Wimpey PLCex-dividend payment date
Tesco PLCex-dividend payment date
TT Electronics PLCdividend payment date
WPP PLCex-dividend payment date
XP Power Ltddividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
3 Oct 2023 18:19

IN BRIEF: GSK's Jemperli approved in UK for endometrial cancer

GSK PLC - London-based pharmaceutical company - On Monday, announces that the UK Medicines & Health Products Regulatory Agency has authorised a new indication for Jemperli, also known as dostarlimab. The drug is used as a treatment for some types of endometrial cancer and an be used to treat patients that have a tumour abnormality called mismatch repair deficient/microsatellite instability-high when the cancer is at an advanced stage when first diagnosed or has returned after previous treatment. It is now authorised to be used together with chemotherapy to slow the progression of these cancers. GSK says it is the first medicine licensed as first line treatment for primary advanced or recurrent endometrial cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.